HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.

Abstract
An siRNA screen targeting 89 IFN stimulated genes in 14 different cancer cell lines pointed to the RIG-I (retinoic acid inducible gene I)-like receptor Laboratory of Genetics and Physiology 2 (LGP2) as playing a key role in conferring tumor cell survival following cytotoxic stress induced by ionizing radiation (IR). Studies on the role of LGP2 revealed the following: (i) Depletion of LGP2 in three cancer cell lines resulted in a significant increase in cell death following IR, (ii) ectopic expression of LGP2 in cells increased resistance to IR, and (iii) IR enhanced LGP2 expression in three cell lines tested. Studies designed to define the mechanism by which LGP2 acts point to its role in regulation of IFNβ. Specifically (i) suppression of LGP2 leads to enhanced IFNβ, (ii) cytotoxic effects following IR correlated with expression of IFNβ inasmuch as inhibition of IFNβ by neutralizing antibody conferred resistance to cell death, and (iii) mouse embryonic fibroblasts from IFN receptor 1 knockout mice are radioresistant compared with wild-type mouse embryonic fibroblasts. The role of LGP2 in cancer may be inferred from cumulative data showing elevated levels of LGP2 in cancer cells are associated with more adverse clinical outcomes. Our results indicate that cytotoxic stress exemplified by IR induces IFNβ and enhances the expression of LGP2. Enhanced expression of LGP2 suppresses the IFN stimulated genes associated with cytotoxic stress by turning off the expression of IFNβ.
AuthorsRyan C Widau, Akash D Parekh, Mark C Ranck, Daniel W Golden, Kiran A Kumar, Ravi F Sood, Sean P Pitroda, Zhengkai Liao, Xiaona Huang, Thomas E Darga, David Xu, Lei Huang, Jorge Andrade, Bernard Roizman, Ralph R Weichselbaum, Nikolai N Khodarev
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 111 Issue 4 Pg. E484-91 (Jan 28 2014) ISSN: 1091-6490 [Electronic] United States
PMID24434553 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Interferon Type I
  • Dhx58 protein, mouse
  • Ddx58 protein, mouse
  • DEAD Box Protein 58
  • DEAD-box RNA Helicases
  • RNA Helicases
Topics
  • Animals
  • Apoptosis
  • Brain Neoplasms (pathology)
  • Cell Survival (physiology)
  • DEAD Box Protein 58
  • DEAD-box RNA Helicases (metabolism, physiology)
  • Glioblastoma (pathology)
  • Humans
  • Interferon Type I (biosynthesis)
  • Mice
  • Mice, Knockout
  • Neoplasms, Experimental (metabolism, pathology)
  • RNA Helicases (metabolism, physiology)
  • Radiation, Ionizing
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: